← Browse by Condition
Medical Condition

pancreatic ductal adenocarcinoma pdac

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 1, Phase 2, Phase 2
NCT06639724 Phase 1
Recruiting

Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer

Enrollment
36 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT07349537 Phase 1
Recruiting

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Enrollment
574 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
View Trial →
NCT07235202 Phase 1, Phase 2
Recruiting

A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy

Enrollment
45 pts
Location
China
Sponsor
Shenzhen Majory Biotechnology ...
View Trial →
NCT07450859 Phase 2
Recruiting

A Study of BT5528 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Enrollment
39 pts
Location
United States
Sponsor
BicycleTx Limited
View Trial →
NCT04575363
Recruiting

RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer

Enrollment
90 pts
Location
France
Sponsor
CHU de Reims
View Trial →